These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


151 related items for PubMed ID: 27704192

  • 21. Vertebral Hemangioma Mimicking Bone Metastasis in 68Ga-PSMA Ligand PET/CT.
    Artigas C, Otte FX, Lemort M, van Velthoven R, Flamen P.
    Clin Nucl Med; 2017 May; 42(5):368-370. PubMed ID: 28319497
    [Abstract] [Full Text] [Related]

  • 22. Prostate-Specific Membrane Antigen-Avid Bone Metastases From Urothelial Carcinoma of the Bladder.
    Zhao B, Dong A, Zuo C.
    Clin Nucl Med; 2022 Oct 01; 47(10):892-894. PubMed ID: 35439183
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [The role of molecular imaging (PET-CT) in the diagnostic and treatment pf prostate cancer].
    Mirzaei S, Knoll P, Zandieh S.
    Wien Med Wochenschr; 2019 Feb 01; 169(1-2):12-14. PubMed ID: 30349972
    [Abstract] [Full Text] [Related]

  • 25. Will 68Ga PSMA-radioligands be the only choice for nuclear medicine in prostate cancer in the near future? A clinical update.
    Cuccurullo V, di Stasio GD, Evangelista L, Ciarmiello A, Mansi L.
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018 Feb 01; 37(2):103-109. PubMed ID: 29422356
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Paget bone disease demonstrated on (68)Ga-PSMA ligand PET/CT.
    Artigas C, Alexiou J, Garcia C, Wimana Z, Otte FX, Gil T, Van Velthoven R, Flamen P.
    Eur J Nucl Med Mol Imaging; 2016 Jan 01; 43(1):195-196. PubMed ID: 26502983
    [No Abstract] [Full Text] [Related]

  • 28. [Rectal mucosa metastasis in recurrent prostate cancer : (68)Ga-PSMA-PET/CT allows targeted salvage radiotherapy].
    Düwel C, Blümel C, Westenfelder K, Wagner-Thiessen E, Becker A, Gschwend JE, Eiber M, Maurer T.
    Urologe A; 2016 Aug 01; 55(8):1086-8. PubMed ID: 27385310
    [Abstract] [Full Text] [Related]

  • 29. 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients.
    Schmidkonz C, Cordes M, Goetz TI, Prante O, Kuwert T, Ritt P, Uder M, Wullich B, Goebell P, Bäuerle T.
    Ann Nucl Med; 2019 Oct 01; 33(10):766-775. PubMed ID: 31338731
    [Abstract] [Full Text] [Related]

  • 30. Fibrous dysplasia mimicking bone metastasis on 68GA-PSMA PET/MRI.
    De Coster L, Sciot R, Everaerts W, Gheysens O, Verscuren R, Deroose CM, Pans S, Van Laere K, Goffin KE.
    Eur J Nucl Med Mol Imaging; 2017 Aug 01; 44(9):1607-1608. PubMed ID: 28488027
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Rib Fractures Mimicking Bone Metastases in 18F-PSMA-1007 PET/CT for Prostate Cancer.
    Panagiotidis E, Paschali A, Giannoula E, Chatzipavlidou V.
    Clin Nucl Med; 2019 Jan 01; 44(1):e46-e48. PubMed ID: 30371591
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Multiphasic 68Ga-PSMA PET/CT in the Detection of Early Recurrence in Prostate Cancer Patients with a PSA Level of Less Than 1 ng/mL: A Prospective Study of 135 Patients.
    Beheshti M, Manafi-Farid R, Geinitz H, Vali R, Loidl W, Mottaghy FM, Langsteger W.
    J Nucl Med; 2020 Oct 01; 61(10):1484-1490. PubMed ID: 32060214
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.